Bakkt is expected to launch its first product, bitcoin futures trading, on January 24, with other products rolling out throughout Optimists believe the launch of Bakkt will cause billions of dollars to pour into the crypto space from institutional investors. A physically settled monthly futures contract for bitcoin held in the Bakkt Warehouse. A much better start. In addition to Bitcoin options, Bakkt also introduced its cash-settled Bitcoin futures that are now available on ICE Futures Singapore. Thus, CME Group should be prepared to face some tough competition. At press time, Bakkt has already managed to trade 1, BTC worth of its USD-settled contracts.
Bakkt bitcoin futures marketBakkt Bitcoin Futures Daily Trading Volume Hits Record High - CoinDesk
Oddly, this argument also works in reverse. If a large venture capital firm is confident in Bakkt, the firms that look to it for guidance will follow suit.
By nature, these types of holdings need to be conservative. They exist, after all, to help investors prepare for the future. Without significant institutional backers, the crypto market has been famously volatile.
In kind of a vicious circle, that lack of institutional money due to volatility has prevented an injection of capital which could keep volatility to a minimum.
This works on a tech angle, as well. Few companies set out to build applications or platforms based on unproven or little-adopted technology. In September Bakkt launched its first physically-settled bitcoin futures products, and to much ado.
Of course, it remains to be seen how precisely Bakkt will fare in the years ahead. Importantly, these futures contracts now serve as benchmarks established by a trusted price discovery process upon which investors can rely. The futures launch went according to schedule, as Loeffler revealed last month that September 23rd was the target release date for the derivatives. However, Bakkt had previously delayed the offerings multiple times as it worked to finalize its preparations.
With the futures contracts now publicly available, Bakkt joins the likes of mainstream derivatives marketplace CME Group, which launched its first bitcoin futures product in December Notably, the Bakkt Bitcoin Futures products are the first in the U.
In November Bakkt opened the doors of its custody services to all the institutions of the world. And while saturation is already accruing near the top of the cryptocurrency custody sector, Bakkt is hoping to beat out the competition by offering its clients a superior service.
Per Bakkt, the first oncomers to use its widened custody offering will be cryptoeconomy mainstays Galaxy Digital, Pantera Capital, and Tagomi. In Ocotober , Bakkt revealed the coming launch of a consumer app , which will be aimed at helping users pay for goods and services from merchants using cryptocurrencies, among other things. On the flip side, the ICE-backed company is also developing a merchant portal, of which popular coffee chain Starbucks will be a launch partner.
We look forward to building on this momentum as we approach the launch of the Bakkt Bitcoin Options contracts on Dec 9th. Cryptocurrency data Twitter page Ecoinometrics recently noted that the open interest in the Bitcoin futures contracts has surged by hundreds of BTC over recent days. Bakkt Bitcoin Futures Activity Report. Oh boy! CME gives you the cash equivalent of the bitcoin.
Physical settlement more closely follows the traditional futures model that has been in place for centuries. They would then get their ton of wheat. At the expiration of a traditional futures contract, you have to wait to take possession of the asset you purchased. Often, the waiting period is 30 days. Using the wheat example, this would give the farmer or co-op providing the wheat time to deliver the goods.
Bakkt, on the other hand, offers one-day settlement on its futures contracts. Bakkt is also offering day bitcoin futures contracts. However, for traders who want quicker liquidity, the one-day settlement option offers significant advantages. For instance, you could be using a futures contract to hedge against other investments that come to fruition at the end of the quarter. Waiting 30 days for your bitcoin to be liquid could significantly delay your next round of investments for the following quarter.
With a one-day settlement period, on the other hand, you can make your next round of investments almost right away. Bitcoin options, like futures, follow the same basic principles as all options. The group is also benefiting from a potential catalyst from a Joe Biden administration that will be more supportive of alternative energy, Cramer said.
What Happened: On Wednesday, Inovio published a paper including Phase 1 data on INO, which was found to have been immunogenic in all test subjects. In addition, Phase 1 testing generated no serious adverse safety events and only six Grade I adverse events, which were mostly minor injection site reactions. Yet Moderna's vaccine must be stored and transported at temperatures of negative 20 Celsius, and Pfizer's vaccine must be stored and transported at temperatures of negative 70 Celsius, colder than winter temperatures in Antarctica.
INO, on the other hand, is stable at room temperature for more than one year. It also doesn't need to be frozen during transporter storage, potentially making it faster and more cost-effective to distribute. Benzinga's Take: Assuming it is as effective and safe as competing vaccines, Inovio's candidate could ultimately end up being the standard-bearer for COVID and future coronavirus vaccine variants.
Bitcoin had an impressive year in , assuming there is no year-end meltdown. Well, almost no one. Believe it or not, being alerted to huge winners before they stage breakout rallies has become par for the course at The Daily 10X. That much is certain. Thanks to falling costs, shifting laws, and improving technology, electric cars, busses, vans and trucks will increasingly become the global norm.
But ubiquity for electric vehicles is a long way off. By extension, nearly all of the automotive manufacturing capacity in the world is wired to create gas and diesel vehicles. But we need to reduce carbon emissions now.
Today, there exists a big gap in the automotive market between robust demand and need for cleaner energy vehicles, and limited supply to meet that demand. Someone has to fill that gap. They have to make some drastic changes, the sum of which will require a lot of time and money. But what if no drastic changes were needed? What if Ford and General Motors could simply make one small tweak to their manufacturing plants, and… voila, produce eco-friendly vehicles?
Surely, that would fix the EV Revolution Gap, no? Xl Fleet has created a proprietary line of eco-friendly powertrains designed for medium-duty commercial vehicles that are simply plug-and-play solutions for auto makers to immediately and cost-effectively decarbonize their fleets. The idea is simple. The company could create an entirely new manufacturing plant for the new van, which would take several quarters and millions of dollars. Or, Ford could keep its old plant, and simply swap in an XL powertrain to improve the fuel efficiency and carbon emissions profile of the van.
Very little extra cost. Very little assembly line adjustment. And almost no added time. In other words, XL Fleet has created a series of powertrain solutions which can be used immediately — and without much extra cost — by fleet operators to reduce carbon emissions.
They are hybrid. These major corporations see XL powertrains as an optimal way to cheapen and accelerate their path towards being reducing emissions. Thereafter, XL Fleet will create a path for them to go fully electric.
The fastest option? The most cost-effective option? The most proven option? The best option? XL powertrains. Both of those new products represent significant addressable market expansions — and could end up being game changers in their own right. They could easily add another few billion dollars in revenue at least and few hundred million dollars in profits again, at least. On the date of publication, Luke Lango did not have either directly or indirectly any positions in the securities mentioned in this article.
Click here to find out how. Click here to sign up now. First thing's first, what are penny stocks? Penny stocks are well-known for their volatility aside from just their cheap price. First, understand what you're buying and why you're buying it. Just saying you trade penny stocks isn't the goal. You're in the market to make money. So, identifying entry and exit targets are obviously important. What's more, is you should have a basic strategy in mind.
Are you looking at day trading penny stocks or do you have a longer-term idea in mind? Also, it's important to account for the swings in price and how fast they're happening. Case in point, small-cap stocks are red hot right now. When finding penny stocks to buy, make sure you assess each trade independently and plan accordingly. Furthermore, day traders wouldn't normally jump into a stock that is barely fluctuating in price. As a rule of thumb, the lower the price, the higher the volatility.
That's simply for the fact that a small move in price equates to a larger percentage change. This week the company came out with news that it finished the purchase of roughly 44 acres in Montana.
This will be the site for its vaccine development and manufacturing facility. This adds to the growing footprint of the company as well. These two facilities will support the development and production of the company's vaccine candidates. Specifically, the TNX has been a center of attention as you could imagine. Many coronavirus vaccine stocks have garnered interest over the last few months. In this case, Tonix is aiming to report efficacy data from animal challenge studies of the vaccine candidate next quarter.
Unlike other biotech's Biolase is mainly focused on products used in oral health. The company's main products are dental laser systems that perform a wide range of procedures, including cosmetic and complex surgical applications. Last month the company launched Waterlase Endo Academy to foster education and best practices for integrating Waterlase technology in clinical settings.
Jaguar Health Inc. While we've reported on the company for weeks, the bigger move this week comes after Jaguar's latest update. The company signed an agreement for a non-dilutive royalty financing transaction. Lisa Conte, Jaguar's president and CEO, explained that, "The timing of this transaction aligns well with the progress of the recently initiated pivotal Phase 3 trial for CTD, for which patient enrollment is progressing.
There's a potential deal with the SPAC and an operational subsidiary of Jaguar to be established in Europe with an exclusive license to crofelemer and Mytesi for the indications of inflammatory diarrhea and HIV-related diarrhea.
Senseonics Holdings Inc. Senseonics was granted a patent titled, "Remotely-powered sensing system with multiple sensing devices. Senseonics' implantable glucose monitoring systems are used by diabetes patients.